Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches.

Frontiers in pharmacology·2026
Same author

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.

Biochemical pharmacology·2026
Same author

Risk Factors for Early Chronic Kidney Disease IV-V in Children with Posterior Urethral Valves: A Retrospective Cohort Study.

Journal of Indian Association of Pediatric Surgeons·2026
Same author

Nitrogen-Doped Carbon Quantum Dots for FRET-Assisted and Smartphone-Enabled Fluorescent Detection of Melatonin in Biological Samples.

Journal of fluorescence·2026
Same author

Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia.

Cancers·2026
Same author

Polymer-Based Linear and Symmetric Artificial Synaptic Memristors for Accurate and Reliable Neuromorphic Computing Applications.

Nanomaterials (Basel, Switzerland)·2026
Same journal

A follow-up cohort study on secondary findings in cancer predisposition genes from 20,205 Chinese individuals.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Chemometric profiling reveals selective circulating bile acid remodeling in Alzheimer's disease.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Serum sialic acid is independently associated with cerebrovascular atherosclerotic stenosis severity and total vascular burden: A retrospective cohort study.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Reference intervals for venous blood gas measurement in a healthy Chinese population.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach.

Clinica chimica acta; international journal of clinical chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K

Biomarkers in sepsis.

Juhi Saxena1, Sarvjeet Das2, Anshu Kumar2

  • 1Department of Biotechnology, Parul Institute of Technology, Parul University, Vadodara, Gujarat, India.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|July 27, 2024
PubMed
Summary
This summary is machine-generated.

Biomarkers are vital for diagnosing sepsis, a life-threatening infection response. This review covers established and emerging biomarkers for early detection, risk assessment, and guiding antimicrobial stewardship to improve patient survival.

Keywords:
Antimicrobial stewardshipBiomarkersDiagnosisRisk stratificationSepsisTranscriptional diagnostics

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

163
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K

Related Experiment Videos

Last Updated: Jun 18, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

163
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Biomarker research

Background:

  • Sepsis is a life-threatening organ dysfunction from infection, causing significant global mortality.
  • Timely diagnosis and treatment are critical for improving sepsis patient survival rates.
  • Biomarkers are essential tools for sepsis diagnosis, risk stratification, and management.

Purpose of the Study:

  • To review current and emerging biomarkers for sepsis diagnosis and management.
  • To explore the application of biomarkers in antimicrobial stewardship and risk assessment.
  • To discuss advancements in transcriptional diagnostics and metagenomic sequencing for sepsis.

Main Methods:

  • Comprehensive literature review of sepsis biomarkers.
  • Analysis of diagnostic and prognostic values of various biomarkers.
  • Exploration of novel approaches like transcriptional diagnostics and metagenomics.

Main Results:

  • Established biomarkers (WBC, CRP, IL-6, PCT) show diagnostic and prognostic utility.
  • Biomarkers aid in guiding antimicrobial therapy and patient risk stratification.
  • Emerging techniques offer deeper insights into host response and microbial identification.

Conclusions:

  • Biomarker-based strategies are crucial for effective sepsis diagnosis and management.
  • Personalized therapy guided by biomarkers can improve clinical outcomes.
  • Future research should focus on integrating novel diagnostic tools for sepsis care.